About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in San Antonio | 33 Studies

Clinical Trials Alzheimer's DiseaseSan Antonio

Alzheimer's Disease Clinical Trials in San Antonio

Find 33 clinical trials for alzheimer's disease near San Antonio, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 33 trials

TerminatedA Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early ADThis is a Phase 2A multi-center, randomized, double blind, placebo-controlled, parallel group study of varoglutamstat, with a stage gate to Phase 2B.NCT03919162·Phoenix, Arizona and 21 others CompletedADvance II Study: DBS-f in Patients With Mild Alzheimer's DiseaseThe primary efficacy objective of this study is to test the hypothesis that DBS-f stimulation (ON) will slow cognitive and functional progression of AD, as compared to no…NCT03622905·Phoenix, Arizona and 20 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEffects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's DiseaseA double-blind, placebo-controlled study that aims to investigate the effect of 2-week and 12-week administration of USP methylene blue (MB) on cerebral blood flow, functional…NCT02380573·San Antonio, Texas

CompletedPilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's DiseaseThe objective of the study is to evaluate the ability of (-)-L-2',3'-dideoxy-3'-thiacytidine (3TC) to engage its intended target, penetrate the central nervous system (CNS)…NCT04552795·San Antonio, Texas and 2 others

CompletedHome-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related…NCT05478681·Houston, Texas and 1 other

RecruitingA Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.NCT07011745·Chandler, Arizona and 143 others

TerminatedA Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseThe primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the…NCT05310071·Gilbert, Arizona and 264 others

RecruitingA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseThis is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD…NCT07094516·Phoenix, Arizona and 73 others

Active not recruitingEscitalopram for Agitation in Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of escitalopram for agitation in Alzheimer's dementia.NCT03108846·Sun City, Arizona and 28 others

TerminatedA Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild…NCT03114657·Scottsdale, Arizona and 210 others

CompletedELND005 in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the dose-related safety and efficacy of multiple oral dosages of ELND005 as treatment for Alzheimer's disease (AD).NCT00568776·Phoenix, Arizona and 61 others

Enrolling by invitationThe Diabetes Prevention Program Outcomes Study AD/ADRD ProjectThe DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2…NCT05704309·Phoenix, Arizona and 26 others

TerminatedSafety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)This randomized, double-blind, placebo-controlled, parallel group study will evaluate the efficacy and safety of gantenerumab versus placebo in participants with early (prodromal…NCT03443973·Phoenix, Arizona and 154 others

Enrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design…NCT05617014·Birmingham, Alabama and 64 others

CompletedA Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseThe main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer…NCT06538116·Phoenix, Arizona and 63 others

Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.NCT06245031·Phoenix, Arizona and 52 others

CompletedStudy of BHV-4157 in Alzheimer's DiseasePreclinical models suggest that riluzole, the active metabolite of BHV-4157, may protect from AD-related pathology and cognitive dysfunction.NCT03605667·Phoenix, Arizona and 43 others

TerminatedA Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseThe main purpose of this study is to investigate the safety and efficacy of the study drug solanezumab in participants with prodromal Alzheimer's disease (AD).NCT02760602·Phoenix, Arizona and 192 others

CompletedPrazosin for Agitation in Alzheimer's DiseaseThe study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease.NCT03710642·Sun City, Arizona and 13 others

RecruitingA Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseThis is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared…NCT06540833·Anaheim, California and 66 others

Page 1 of 2Next

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia